Clinical Trial Update: SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent Asthma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Symbicort as a single inhaler therapy for persistent asthma in adolescents and adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED